viIMMUNE is an emerging biopharmaceutical company dedicated to the discovery and commercialization of innovative antiviral drugs. As a clinical stage company, exploits small molecules as inhibitors of different enzymes in pathogenic viruses life cycle. Our mission at viIMMUNE is to help alleviate human suffering by discovering long-acting antiviral therapeutics through innovative approaches.